| Literature DB >> 19682054 |
Abstract
Antiepileptic drugs (AEDs) remain a first treatment approach in Landau-Kleffner syndrome (LKS) and related syndromes. In the current literature, only class IV evidence is available. Inclusion criteria and outcome parameters are ill-defined. Most commonly, valproate, ethosuximide, and/or benzodiazepines are used. More recent case series show that sulthiame and especially levetiracetam can be considered as effective drugs. Smaller studies also point to the ketogenic diet as a valuable treatment option in LKS.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19682054 DOI: 10.1111/j.1528-1167.2009.02222.x
Source DB: PubMed Journal: Epilepsia ISSN: 0013-9580 Impact factor: 5.864